HSHHSH Health Technology Supplier Hub

All suppliers

Showing 76–100 of 278

Elsevier HealthHQ Netherlands · Europe
Clinical AI & decision support

Parent RELX (REL.L) group FY2025 revenue £9.59bn (+1.7%); operating margin 31.6%; net income £2.08bn.

Figures cover the whole listed group, not this business alone.

Financial health: StrongRisk summary →
No reviews yet
View profile
EMISHQ United Kingdom · Europe
Electronic health records (EHR/EPR)Primary care systems

Parent UnitedHealth Group (UNH) group FY2025 revenue $447.57bn (+11.8%); operating margin 4.2%; net income $12.06bn.

Optum: revenue $270.6bn (+7%), earnings from operations $9.5bn.

Financial health: FairRisk summary →
No reviews yet
View profile
Epic SystemsHQ United States · North America
Electronic health records (EHR/EPR)Patient engagement & accessPopulation health & analyticsRevenue cycle, billing & claims

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
EsaoteHQ Italy · Europe
Imaging, PACS & RIS

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Experian HealthHQ United States · North America
Revenue cycle, billing & claims

Parent Experian (EXPN.L) group FY2026 revenue $8.45bn (+12.3%); operating margin 24.2%.

Benchmark EBIT $2.40bn (+15%); net debt 1.7x Benchmark EBITDA.

Financial health: StrongRisk summary →
No reviews yet
View profile
ezCaretechHQ South Korea · Asia-Pacific
Electronic health records (EHR/EPR)

Listed (099750.KQ).

Latest full-year results not yet captured by HSH.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
First DatabankHQ United States · North America
Pharmacy & medicines management

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Flatiron HealthHQ United States · North America
Clinical trials & life sciencesElectronic health records (EHR/EPR)

Parent Roche (ROG.SW) group FY2025 revenue CHF 61.52bn (+2.0%); core operating margin 35.5%; net income CHF 13.80bn.

Diagnostics division sales CHF 13.85bn (+2% at constant exchange rates).

Financial health: StrongRisk summary →
No reviews yet
View profile
FortinetHQ United States · North America
Cyber security

FY2025 revenue $6.80bn (+14.2%); operating margin 30.7%; net income $1.85bn.

Cash $3.92bn; debt $996.3m.

Financial health: StrongRisk summary →
No reviews yet
View profile
Foundation MedicineHQ United States · North America
Genomics & precision medicine

Parent Roche (ROG.SW) group FY2025 revenue CHF 61.52bn (+2.0%); core operating margin 35.5%; net income CHF 13.80bn.

Diagnostics division sales CHF 13.85bn (+2% at constant exchange rates).

Financial health: StrongRisk summary →
No reviews yet
View profile
Fujifilm HealthcareHQ Japan · Asia-Pacific
Imaging, PACS & RIS

Parent Fujifilm Holdings (4901.T) group FY2025 revenue ¥3.36tn (+5.0%); operating margin 10.4%; net income ¥276.7bn.

Group figures; Healthcare is one of several segments.

Financial health: StrongRisk summary →
No reviews yet
View profile
FujitsuHQ Japan · Asia-Pacific
Electronic health records (EHR/EPR)Infrastructure & cloud

Listed (6702.T).

Latest full-year results not yet captured by HSH.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
GE HealthCareHQ United States · North America
Clinical AI & decision supportImaging, PACS & RISMedical devices & monitoring

FY2025 revenue $20.62bn (+4.8%); operating margin 13.4%; net income $2.08bn.

Cash $4.51bn; debt $10.00bn.

Financial health: StrongRisk summary →
No reviews yet
View profile
GetingeHQ Sweden · Europe
Medical devices & monitoringSurgical & theatre systems

FY2025 adjusted EBITA SEK 4.88bn, a 14.0% adjusted margin; organic growth 4.9%.

Band uses the adjusted margin; reported net sales and profit not yet captured.

Financial health: StrongRisk summary →
No reviews yet
View profile
GleamerHQ France · Europe
Clinical AI & decision supportImaging, PACS & RIS

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Google CloudHQ United States · North America
Clinical AI & decision supportInfrastructure & cloud

Parent Alphabet (GOOGL) group FY2025 revenue $402.84bn (+15.1%); operating margin 32.0%; net income $132.17bn.

Figures cover the whole listed group, not this business alone.

Financial health: StrongRisk summary →
No reviews yet
View profile
Graphnet HealthHQ United Kingdom · Europe
Interoperability & integrationPopulation health & analytics

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Greenway HealthHQ United States · North America
Electronic health records (EHR/EPR)Revenue cycle, billing & claims

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
GrifolsHQ Spain · Europe
Diagnostics & IVD

FY2025 revenue €7.52bn (+7.0%); net margin 5.3%; net income €402.0m.

Net profit more than doubled; EBIT and leverage not captured.

Financial health: FairRisk summary →
No reviews yet
View profile
HalodocHQ Indonesia · Asia-Pacific
Telehealth & virtual care

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Health CatalystHQ United States · North America
Clinical AI & decision supportPopulation health & analytics

FY2025 revenue $311.1m (+1.5%); operating margin -51.7%; net loss $178.0m.

Cash $95.7m; debt $153.3m.

Financial health: WeakRisk summary →
No reviews yet
View profile
Health GorillaHQ United States · North America
Interoperability & integration

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
HealthEngineHQ Australia · Asia-Pacific
Patient engagement & access

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile